City
Epaper

Vitamin D may not protect from Covid infection or severity

By IANS | Updated: June 2, 2021 16:00 IST

Toronto, June 2 Genetic evidence does not support vitamin D as a protective measure against Covid-19, say researchers....

Open in App

Toronto, June 2 Genetic evidence does not support vitamin D as a protective measure against Covid-19, say researchers.

The team from McGill University in Quebec, Canada, analyzed genetic variants of 4,134 individuals with Covid-19, and 1,284,876 without Covid-19, from 11 countries to determine whether genetic predisposition for higher vitamin D levels were associated with less-severe disease outcomes in people with Covid-19.

The results, published in PLOS Medicine, showed no evidence for an association between genetically predicted vitamin D levels and Covid-19 susceptibility, hospitalisation, or severe disease. This suggests that raising circulating vitamin D levels through supplementation may not improve Covid-19 outcomes in the general population.

Increased vitamin D levels, as reflected by 25-hydroxy vitamin D measurements, have been proposed to protect against Covid-19 based on in vitro, observational, and ecological studies.

But, "Vitamin D supplementation as a public health measure to improve outcomes is not supported by this study," said researchers including Guillaume Butler-Laporte and Tomoko Nakanishi from the varsity.

However, the team noted several limitations, including that the research did not include individuals with vitamin D deficiency, and it remains possible that truly deficient patients may benefit from supplementation for Covid-19 related protection and outcomes.

Additionally, the genetic variants were obtained only from individuals of European ancestry, so future studies will be needed to determine the relationship with Covid-19 outcomes in other populations.

A previous study also showed similar results. Scientists from the University of Sao Paulo conducted a clinical trial in Brazil with 240 patients who were given 200,000 IU of vitamin D3 on admission to hospital.

The supplementation did not reduce length of stay or affect the proportion requiring intensive care, according to the study published in the Journal of the American Medical Association (JAMA).

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Institute of Economic Research FoundationtorontocanadaMcgill UniversityCity of torontoMcgillIndia canadaMcgill university in canada
Open in App

Related Stories

MumbaiMumbai: Four Youths Duped of ₹14.72 Lakh with Fake Canada Job Promises

NationalAir India Increases Flights to Toronto, Frankfurt, and Paris To Clear Rush

MumbaiMumbai: Canadian PM Mark Carney Landing Tomorrow, Bilateral Talks With PM Modi in Delhi Scheduled

CricketT20 World Cup 2026 Standings: Updated Points Table After Australia vs Oman Match

CricketT20 World Cup 2026 Standings: Updated Points Table After Afghanistan vs Canada Match

Health Realted Stories

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns

HealthIndia’s millet push receives dual boost at technology and grassroots levels

HealthUK heart rhythm expert now performing procedures in India